J.D.

Mass Tort Landscape 2025: Key Cases, Trends & Strategic Opportunities

The mass tort landscape is evolving rapidly, with new cases gaining momentum and established litigations reaching critical phases. For law firms and legal marketers, timing is everything—success hinges on anticipating trends, securing high-value claimants early, and deploying targeted campaigns that resonate with affected communities. In this exclusive breakdown, we analyze the most impactful mass torts …

Mass Tort Landscape 2025: Key Cases, Trends & Strategic Opportunities Read More »

Zyprexa & Risperdal 2: The Breast Cancer Link That Could Ignite the Next Mass Tort

The pharmaceutical litigation landscape has seen its share of blockbuster cases—from opioid multidistrict litigations to the ongoing Paraquat Parkinson’s claims. But a new California lawsuit (Brown v. Johnson & Johnson et al.) could revive two legacy antipsychotics with a startling twist: breast cancer allegations tied to prolactin elevation. The Plot Twist: From Gynecomastia to Oncology For …

Zyprexa & Risperdal 2: The Breast Cancer Link That Could Ignite the Next Mass Tort Read More »

Best Case Leads